Related references
Note: Only part of the references are listed.Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction Detailed Phenotypes, Prognosis, and Response to Spironolactone
Jordana B. Cohen et al.
JACC-HEART FAILURE (2020)
Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization
Guillermo Lopez-Lluch et al.
NUTRITION (2019)
Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction
Anupam A. Kumar et al.
CIRCULATION (2019)
Epidemiology of heart failure with preserved ejection fraction
Shannon M. Dunlay et al.
NATURE REVIEWS CARDIOLOGY (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Hypoxia-Inducible Factor-1α Mediates Increased Sympathoexcitation via Glutamatergic N-Methyl-D-Aspartate Receptors in the Paraventricular Nucleus of Rats With Chronic Heart Failure
Neeru M. Sharma et al.
CIRCULATION-HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Cardiovascular disease in Europe - epidemiological update 2015
Nick Townsend et al.
EUROPEAN HEART JOURNAL (2015)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2015)
The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure Results From Q-SYMBIO: A Randomized Double-Blind Trial
Svend A. Mortensen et al.
JACC-HEART FAILURE (2014)
Comparison Study of Plasma Coenzyme Q(10) Levels in Healthy Subjects Supplemented With Ubiquinol Versus Ubiquinone
Peter H. Langsjoen et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2014)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Epidemiology and clinical course of heart failure with preserved ejection fraction
Carolyn S. P. Lam et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Sherif F. Nagueh et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2009)
Coenzyme Q(10) (CoQ(10)) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM)
K. Adarsh et al.
BIOFACTORS (2008)
Coenzyme Q10 An Independent Predictor of Mortality in Chronic Heart Failure
Sarah L. Molyneux et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
How to diagnose diastolic heart failure:: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Walter J. Paulus et al.
EUROPEAN HEART JOURNAL (2007)
Coenzyme Q10 and exercise training in chronic heart failure
Romualdo Belardinelli et al.
EUROPEAN HEART JOURNAL (2006)
Trends in heart failure incidence and survival in a community-based population
VL Roger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Overview on coenzyme Q(10) as adjunctive therapy in chronic heart failure. Rationale, design and end-points of Q-symbio - A multinational trial
SA Mortensen
BIOFACTORS (2003)
Long-term trends in the incidence of and survival with heart failure
D Levy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
New concepts in diastolic dysfunction and diastolic heart failure: Part II - Causal mechanisms and treatment
MR Zile et al.
CIRCULATION (2002)
Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure
PH Langsjoen
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
